Today's Date: December 3, 2022
Dennis Amos, Vice President of Planning & Analysis for The Twenty-Nine Palms Band of Mission Indians, "QCI's Dynamic Reinves   •   GENERAC HOLDINGS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losse   •   The Law Offices of Frank R. Cruz Announces Investigation of Generac Holdings Inc. (GNRC) on Behalf of Investors   •   Leading National Prostate Cancer Nonprofit Spearheads Influential HHS Moonshot Meeting   •   Reducing licensed child care fees for British Columbia families by 50%   •   Jack Nathan Health Provides Corporate Update   •   Louisiana local Ronnie Schwartz clinches St. Jude Hero Among Us Award   •   Canada Revenue Agency's Disability Advisory Committee submits 10 recommendations in its third annual report   •   PROVIDENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Provident Bancorp, Inc. on Behalf of Provident Stockholders an   •   Savory & Partners: Birthright citizenship and the exciting world of birth tourism   •   Ismael Cala invites you to plan and manifest 2023 as the best year of our lives   •   INVESTOR DEADLINE: Olaplex Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit &ndash   •   OPENDOOR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Op   •   Bark Technologies Announces a Strategic MVNO Agreement with T-Mobile Enabling Mobile Service for its Bark Phone Featuring Childr   •   PAYPAL HOLDINGS, INC. DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fil   •   EHEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Of   •   'Tis the Season for Giving Back at Jim Ellis Automotive   •   The Canadian Association of Journalists is now accepting nominations for its 2022 Awards program   •   MSCI Uplifted GTJAl's ESG Rating, Stating That Its Corporate Governance Leads Global Peers   •   GENERAC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Generac Holdings, In
Bookmark and Share

Koning Celebrates Launch of Koning Clinic with Ribbon-Cutting Event

Koning Celebrates Launch of Koning Clinic with Ribbon-Cutting Event

PR Newswire

NORCROSS, Ga., Sept. 27, 2022 /PRNewswire/ -- Last week, Koning Corporation was joined by top minds in the health, tech, and financial industries, for the inauguration of their new Koning Clinic. This event signifies the start of a new era for the company, as Koning begins to expand its operations across the country via retail clinics.

"It was amazing to meet all of the many investors, some of whom flew in internationally to support Koning," says Matthew Stack, Koning CFO. "To see such a global support network is inspiring and humbling to all of the Koning team."

The ribbon-cutting event came shortly after the announcement of a Koning partnership with innovation firm, 11TEN, and DocPanel, a third-party reading community of subspecialty radiologists.

"With our partnerships in place with 11TEN and DocPanel, we are primed to grow into walk-in clinics - a huge step forward in increasing accessibility to women everywhere," says Naomi Cosman, VP of Marketing at Koning. "The event last week was our announcement to the patient and healthcare communities that we are ready to provide better breast imaging options to every woman, no matter where she chooses to receive her exam."

The Koning Clinic in Norcross will be managed by Dr. John A. Cutrone of Emory/St. Francis in Columbus, GA. The opening of this clinic indicates a milestone in the company's process of receiving its screening indication.

About Koning: Koning is a global Health Technology company focused on improving the breast imaging industry with its patented Koning Breast CT. Koning Breast CT (KBCT 1000) is FDA PMA approved. Koning's vision is to create a revolution in medical imaging through advanced computed tomography technology that dramatically improves the way clinicians visualize and evaluate breast tissue. The KBCT is expected to optimize early disease detection, diagnosis, intervention, and treatment, and will improve survival rates for millions of patients worldwide.

For more information, please visit Koning's website or email Koning at To invest in Koning, please go to the company's profile on StartEngine.

Media Contact:

Cision View original content to download multimedia:

SOURCE Koning Corporation

Back to top
| Back to home page

White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News